Medical Developments International Limited
MDDVF
$0.3206
-$0.187-36.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 32.51% | 35.60% | -3.48% | -5.86% | 7.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.51% | 35.60% | -3.48% | -5.86% | 7.74% |
| Cost of Revenue | 29.10% | 32.12% | -23.80% | -25.69% | 0.17% |
| Gross Profit | 33.77% | 36.90% | 6.52% | 3.90% | 10.84% |
| SG&A Expenses | -43.40% | -42.08% | -34.46% | -36.07% | 39.06% |
| Depreciation & Amortization | 4.62% | 7.09% | 20.52% | 17.55% | -4.53% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.65% | -28.00% | -29.30% | -31.05% | 28.17% |
| Operating Income | 109.37% | 109.59% | 75.05% | 75.66% | -69.37% |
| Income Before Tax | 102.48% | 102.54% | -80.41% | -75.96% | -459.67% |
| Income Tax Expenses | 100.70% | 100.73% | 455.71% | 446.92% | -310.91% |
| Earnings from Continuing Operations | 102.78% | 102.84% | -258.55% | -249.71% | -508.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 102.78% | 102.84% | -258.55% | -249.71% | -508.07% |
| EBIT | 109.37% | 109.59% | 75.05% | 75.66% | -69.37% |
| EBITDA | 126.38% | 126.99% | 74.90% | 74.75% | -91.48% |
| EPS Basic | 102.18% | 102.17% | -258.44% | -250.15% | -489.62% |
| Normalized Basic EPS | 101.99% | 101.98% | 68.20% | 68.97% | -51.00% |
| EPS Diluted | 102.18% | 102.17% | -258.44% | -249.09% | -517.17% |
| Normalized Diluted EPS | 101.99% | 101.98% | 68.20% | 68.97% | -62.37% |
| Average Basic Shares Outstanding | 24.41% | 24.41% | 0.04% | 0.04% | 4.90% |
| Average Diluted Shares Outstanding | 30.44% | 30.44% | 0.04% | 0.04% | -2.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |